Neonatal porcine pancreatic cell clusters as a potential source for transplantation in humans: Characterization of proliferation, apoptosis, xenoantigen expression and gene delivery with recombinant AAV

Xenotransplantation

Volumn 9, Issue 1, 2002, Pages 14-24

  Vizzardelli, Caterina ^a,c   Molano, R Damaris ^a   Pileggi, Antonello ^a   Berney, Thierry ^a   Cattan, Pierre ^a,d   Fenjves, Elizabeth S ^a   Peel, Alyson ^b   Fraker, Chris ^a   Ricordi, Camillo ^a   Inverardi, Luca ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

AAV; Gene delivery; Islets cell proliferation; Neonatal pig islets; Pig islets; Transduction; Xenoantigen expression

Indexed keywords

ANTIGEN; EPITOPE; GALACTOSE; GLUCAGON; HETEROANTIGEN; HORMONE; INSULIN; SOMATOSTATIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL TRANSPLANTATION; DIABETES MELLITUS; GENE TARGETING; GENETIC TRANSDUCTION; INSULIN RELEASE; MOUSE; NEWBORN; NONHUMAN; NUDE MOUSE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL; REPORTER GENE; STREPTOZOCIN DIABETES; SWINE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, HETEROPHILE; ANTIGENS, HETEROPHILE; APOPTOSIS; BROMODEOXYURIDINE; CELL DIVISION; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICROSCOPY, CONFOCAL; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036461346     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2002.0o128.x     Document Type: Article

References (42)

1. HERING BJ, RICORDI C. Islet transplantation for patients with Type 1 Diabetes. Graft 1999; 2: 12.
2. KENYON NS, RANUNCOLI A, MASETTI M, CHATZIPETROU M, RICORDI C. Islet transplantation: present and future perspectives. Diabetes Metab Rev 1998; 14: 303.
3. SMITH RM, MANDEL TE. Transplantation treatment for diabetes. Immunol Today 1998; 19: 444.
4. SHAPIRO AM, LAKEY JR, RYAN EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
5. KENYON NS, CHATZIPETROU M, MASETTI M et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A 1999; 96: 8132.
6. KENYON NS, FERNANDEZ LA, LEHMANN R et al. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 1999; 48: 1473.
7. THOMAS FT, RICORDI C, CONTRERAS JL et al. Reversal of naturally occurring diabetes in primates by unmodified islet xenografts without chronic immunosuppression. Transplantation 1999; 67: 846.
8. PURSEL VG, PINKERT CA, MILLER KF et al. Genetic engineering of livestock. Science 1989; 244: 1281.
9. FODOR WL, WILLIAMS BL, MATIS LA et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyper-acute organ rejection. Proc Natl Acad Sci USA 1994; 91: 11153.
10. MCCURRY KR, KOOYMAN DL, ALVARADO CG et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995; 1: 423.
11. ROSENGARD AM, CARY NR, LANGFORD GA et al. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 1995; 59: 1325.
12. SHARMA A, OKABE J, BIRCH P et al. Reduction in the level of Gal (alphal,3) Gal in transgenic mice and pigs by the expression of an alpha (1,2) fucosyltrans ferase. Proc Natl Acad Sci USA 1996; 93: 7190.
13. RICORDI C, SOCCI C, DAVALLI AM et al. Isolation of the elusive pig islet. Surgery 1989; 107: 688.
14. RICORDI C, FINKE EH, PAUL E, LACY. A method for the mass isolation of islets from the adult pig pancreas. Diabetes 1986; 35: 649.
15. INVERARDI L, RICORDI C. Adult pigs as a source of insulin-producing tissue for xenotransplantation: Islet separation technology. Xenotransplantation 1995; 2: 169.
16. SOCCI C, RICORDI C, DAVALLI AM et al. Selection of donor significantly improves pig islet isolation yield. Hormone Metab Res 1990; 25 (Suppl. 1): 32.
17. KORBUTT GS, ELLIOT JF, ZILIANG AO et al. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 1996; 97: 2119.
18. WEIR GC, QUICKEL RR, KUN-HO Y et al. Porcine neonatal pancreatic cell clusters (NPCC): a potential source of tissue for islet transplantation. Ann Transplant 1997; 2: 63.
19. RAYAT GR, RAJOTIE RV, KORBUTT GS. Potential application of neonatal porcine islets as treatment for type 1 diabetes: a review. Ann NY Acad Sci 1999; 875: 175.
20. PEEL AL, KLEIN RL. Adeno-associated virus vectors: activity and applications in the CNS. J Neurosci Methods 2000 (in press).
21. ZOLOTUKHIN S, BYRNE BJ, MASON E et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999; 6: 973.
22. YOON KH, QUICKEL RR, TATARKIEWICZ K et al. Differentiation and expansion of beta cell mass in porcine neonatal pancreatic cell clusters transplanted into nude mice. Cell Transplant 1999; 8: 673.
23. GALILI U, RACHMILEWITZ EA, PELEG A, FLECHNER I. A unique natural human IgG antibody with anti-α-galactosyl specificity. J Exp Med 1984; 160: 1519.
24. SANDRIN MS, VAUGHAN HA, DABKOWSKI PL, MCKENZIE IFC. Anti-pig IgM antibodies in human serum react predominantly with Gal α(1-3) Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
25. Oriol RYEY,Koren E, COOPER DK. Carbohydrates antigens of pig tissue reacting with human natural antibodies as potential target for hyperacute vascular rejection in pig to man organ xenotransplantation. Transplantation 1993; 56: 1433.
26. INVERARDI L, PARDI R. Early events in cell-mediated recognition of vascularized xenografts: cooperative interactions between selected lymphocyte subsets and natural antibodies. (Review). Immunol Rev 1994; 141: 71.
27. INVERARDI L, CUISSI B, STOLZER AL, BENDER JR, SANDRIN SM, PARDI R. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues. Transplantation 1997; 63: 1318.
28. MIRENDA V, LE MAUFF B, CASSARD A et al. Intact pig pancreatic islet function in the presence of human xenoreactive natural antibody binding and complement activation. Transplantation 1997; 63: 1452.
29. BENDA B, SANDBERG JO, HOLSTAD M, KORSGREN O. T cells in islet-like cell cluster xenograft rejection: a study in the pig-to-mouse model. Transplantation 1998; 66: 435.
30. SODERLUND J, WENNBERG L, CASTANOS-VELEZ E et al. Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 1999; 67: 784.
31. RAYAT GR, RAJOTTE RV, ELLIOTT JF, KORBUTT GS. Expression of Gal alpha (1,3) gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis. Diabetes 1998; 47: 1406.
32. MCKENZIE IFC, KOULMANDA M, MANDEL TE, XING P-X, SANDRIN MS. Pig to human Xenotransplantation: the expression of Gal α(1-3) Gal epitopes on pig islet cells. Xenotransplantation 1995; 2: 1.
33. MCKENZIE IF, KOULMANDA M, MANDEL TE, SANDRIN MS. Pig islet xenografts are susceptible to 'anti-pig' but not Gal alpha (1,3) Gal antibody plus complement in Gal o/o mice. J Immunol. 1998; 161: 5116.
34. BENHAMOU PY, MORISCOT C, PREVOST P et al. Standardization of procedure for efficient ex vivo gene transfer into porcine pancreatic islets with cationic liposomes. Transplantation, 1997; 63 (12): 1798-1803.
35. FENG S, QUICKEL RR, HOLLISTER-LOCK J et al. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig. Transplantation 1999; 67: 1607.
36. JUDGE TA, DESAI NM, YANG Z et al. Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival. Transplantation 1998; 66: 426.
37. GREY ST, ARVELO MB, HASENKAMP W, BACH FH, FERRAN C. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med 1999; 190: 1135.
38. GIANNOUKAKIS N, MI Z, GAMBOTTO A et al. Infection of intact human islets by a lentiviral vector. Gene Ther 1999; 6: 1545.
39. GIANNOUKAKIS N, RUDERT WA, GHIVIZZANI SC et al. Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 1999; 48: 1730.
40. RABINOVITCH A, SUAREZ-PINZON W, STRYNADKA K et al. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 1999; 48: 1223.
41. UCHIKOSHI F, YANG ZD, ROSTAMI S. et al. Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes 1999; 48: 652.
42. GALLICHAN WS, KAFRI T, KRAHL T, VERMA IM. SARVETNICK N. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 1998; 9: 2717.